Explore Cartalax dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions.
Cartalax is a short synthetic peptide bioregulator (Ala-Glu-Asp-Pro) from the Khavinson family of organ-specific peptides, studied in Russian-language literature for its proposed role in cartilage and connective-tissue regulation and musculoskeletal recovery. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Cartalax.
Cartalax is a synthetic tetrapeptide (Ala-Glu-Asp-Pro) from the Khavinson short-peptide bioregulator program, sourced for cartilage and joint-aging research. It ships as a lyophilized powder you reconstitute with bacteriostatic water, and its sequence differs from Cardiogen by a single residue.
In the Khavinson framework, Cartalax is proposed to act through direct binding to gene-promoter DNA in chondrocytes, selectively modulating transcription of genes involved in collagen synthesis, extracellular-matrix turnover, and chondroprotection. This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.
Russian single-site studies have reported Cartalax as an adjunct in age-related osteoarthritis and intervertebral-disc degeneration, with reported improvements in pain scores and joint mobility versus standard care. These studies are not blinded or placebo-controlled, and no Western Phase 2 or 3 trial has been registered.
Cartalax has a reported half-life of ~few hours (bioregulator estimate), and the dose intervals researchers model most often fall around once daily. Short plasma half-life with daily dosing means no meaningful buildup. The benefit of a course is thought to persist beyond the dosing window. It is catalogued under Recovery Peptides on WPA.
51 Cartalax reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (29 calculations). The most common bacteriostatic water volume is 2mL. The most popular vial size is 20mg (46 sessions). The most common dosing frequency is daily (7x/week) (8 logged protocols), followed by once weekly (1).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.